论文部分内容阅读
本文通过青蒿脂纳Ⅰ期临床药代动学的研究提示本品在健康人体内消除速度较快,并与剂量有相关关系,建议临床应用时适当增加给药次数,维持血中药物浓度,以彻底控制疟原虫.
This article through the study of Arteriosclerosis Phase I clinical pharmacokinetics suggests that this product is rapidly eliminated in healthy humans and has a correlation with dose. It is recommended that the number of administrations should be appropriately increased in clinical applications to maintain the blood drug concentration. To completely control Plasmodium.